HNF4A and neoplasm: As HNF4α suppresses EMT31,34–36, the shared metabolic changes between above two cell types suggest that defective SAA metabolism driven by HNF4α deficiency could be a feature of EMT, which is commonly associated with tumor metastasis and drug resistance53.